Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5237 | 1652 | 40.1 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
116 | 3 | MUTATION RESEARCH//TOXICOLOGY//CARCINOGENESIS | 70215 |
3033 | 2 | CARCINOGENESIS//HEPATOCARCINOGENESIS//MEDIUM TERM BIOASSAY | 2478 |
5237 | 1 | CARCINOGENESIS//MEDIUM TERM BIOASSAY//FOCI OF ALTERED HEPATOCYTES | 1652 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CARCINOGENESIS | journal | 193670 | 21% | 3% | 348 |
2 | MEDIUM TERM BIOASSAY | authKW | 164386 | 1% | 68% | 13 |
3 | FOCI OF ALTERED HEPATOCYTES | authKW | 159734 | 1% | 79% | 11 |
4 | HEPATOCARCINOGENESIS | authKW | 127043 | 5% | 9% | 80 |
5 | ENZYME ALTERED FOCI | authKW | 83161 | 1% | 50% | 9 |
6 | TRANS 4 ACETYLAMINOSTILBENE | authKW | 73929 | 0% | 100% | 4 |
7 | GST P POSITIVE FOCI | authKW | 71073 | 1% | 38% | 10 |
8 | SEZ PATOL SPERIMENTALE ONCOL | address | 66531 | 0% | 60% | 6 |
9 | DIETHYLNITROSAMINE | authKW | 59949 | 2% | 10% | 31 |
10 | INITIATION ASSAY | authKW | 59141 | 0% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 20609 | 57% | 0% | 947 |
2 | Toxicology | 6037 | 19% | 0% | 306 |
3 | Pathology | 2066 | 11% | 0% | 174 |
4 | CYTOLOGY & HISTOLOGY | 598 | 1% | 0% | 16 |
5 | Gastroenterology & Hepatology | 53 | 3% | 0% | 42 |
6 | Medicine, Research & Experimental | 28 | 3% | 0% | 46 |
7 | Pharmacology & Pharmacy | 20 | 5% | 0% | 81 |
8 | Public, Environmental & Occupational Health | 20 | 3% | 0% | 48 |
9 | Biochemistry & Molecular Biology | 18 | 8% | 0% | 132 |
10 | Biophysics | 12 | 2% | 0% | 36 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SEZ PATOL SPERIMENTALE ONCOL | 66531 | 0% | 60% | 6 |
2 | OCCUPAT TOXICOL GRP | 41583 | 0% | 75% | 3 |
3 | ABT CYTOPATHOL 0310 | 36964 | 0% | 100% | 2 |
4 | BIOSTAT R0700 | 36964 | 0% | 100% | 2 |
5 | UNITE BIOCHEM TOXICOL CANCEROL | 36964 | 0% | 100% | 2 |
6 | ABT KREBSFOR | 24642 | 0% | 67% | 2 |
7 | MED MCARDLE CANC | 23759 | 0% | 43% | 3 |
8 | BIOSTAT 2070 | 18482 | 0% | 100% | 1 |
9 | CELL PATHOL 0310 | 18482 | 0% | 100% | 1 |
10 | CYTOPATHOL ABT 0310 | 18482 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARCINOGENESIS | 193670 | 21% | 3% | 348 |
2 | CANCER LETTERS | 22316 | 7% | 1% | 121 |
3 | GANN | 20780 | 2% | 4% | 29 |
4 | TOXICOLOGIC PATHOLOGY | 16691 | 3% | 2% | 48 |
5 | JAPANESE JOURNAL OF CANCER RESEARCH | 14043 | 3% | 1% | 52 |
6 | CANCER RESEARCH | 8258 | 8% | 0% | 133 |
7 | VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY | 7130 | 1% | 2% | 22 |
8 | TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS | 4689 | 1% | 2% | 14 |
9 | EKSPERIMENTALNAYA ONKOLOGIYA | 3797 | 1% | 1% | 16 |
10 | PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY/BK SERIES | 3471 | 0% | 5% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MEDIUM TERM BIOASSAY | 164386 | 1% | 68% | 13 | Search MEDIUM+TERM+BIOASSAY | Search MEDIUM+TERM+BIOASSAY |
2 | FOCI OF ALTERED HEPATOCYTES | 159734 | 1% | 79% | 11 | Search FOCI+OF+ALTERED+HEPATOCYTES | Search FOCI+OF+ALTERED+HEPATOCYTES |
3 | HEPATOCARCINOGENESIS | 127043 | 5% | 9% | 80 | Search HEPATOCARCINOGENESIS | Search HEPATOCARCINOGENESIS |
4 | ENZYME ALTERED FOCI | 83161 | 1% | 50% | 9 | Search ENZYME+ALTERED+FOCI | Search ENZYME+ALTERED+FOCI |
5 | TRANS 4 ACETYLAMINOSTILBENE | 73929 | 0% | 100% | 4 | Search TRANS+4+ACETYLAMINOSTILBENE | Search TRANS+4+ACETYLAMINOSTILBENE |
6 | GST P POSITIVE FOCI | 71073 | 1% | 38% | 10 | Search GST+P+POSITIVE+FOCI | Search GST+P+POSITIVE+FOCI |
7 | DIETHYLNITROSAMINE | 59949 | 2% | 10% | 31 | Search DIETHYLNITROSAMINE | Search DIETHYLNITROSAMINE |
8 | INITIATION ASSAY | 59141 | 0% | 80% | 4 | Search INITIATION+ASSAY | Search INITIATION+ASSAY |
9 | 2 ACETYLAMINOFLUORENE | 52921 | 1% | 15% | 19 | Search 2+ACETYLAMINOFLUORENE | Search 2+ACETYLAMINOFLUORENE |
10 | PRENEOPLASTIC HEPATOCYTES | 49283 | 0% | 67% | 4 | Search PRENEOPLASTIC+HEPATOCYTES | Search PRENEOPLASTIC+HEPATOCYTES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PITOT, HC , (1990) ALTERED HEPATIC FOCI - THEIR ROLE IN MURINE HEPATOCARCINOGENESIS.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 30. ISSUE . P. 465-500 | 123 | 73% | 158 |
2 | ENZMANN, HG , BRUNNEMANN, KD , KAESTNER, B , IATROPOULOS, MJ , WILLIAMS, GM , (2014) DOSE-DEPENDENT INDUCTION OF PRENEOPLASTIC LESIONS BY THE TOBACCO-SPECIFIC NITROSAMINE CARCINOGEN NNK IN THE IN OVO CARCINOGENICITY ASSESSMENT (IOCA) ASSAY.EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY. VOL. 66. ISSUE 1. P. 35-40 | 29 | 83% | 0 |
3 | WHYSNER, J , ROSS, PM , WILLIAMS, GM , (1996) PHENOBARBITAL MECHANISTIC DATA AND RISK ASSESSMENT: ENZYME INDUCTION, ENHANCED CELL PROLIFERATION, AND TUMOR PROMOTION.PHARMACOLOGY & THERAPEUTICS. VOL. 71. ISSUE 1-2. P. 153 -191 | 69 | 47% | 143 |
4 | DRAGAN, YP , PITOT, HC , (1992) THE ROLE OF THE STAGES OF INITIATION AND PROMOTION IN PHENOTYPIC DIVERSITY DURING HEPATOCARCINOGENESIS IN THE RAT.CARCINOGENESIS. VOL. 13. ISSUE 5. P. 739-750 | 76 | 54% | 63 |
5 | LEE, GH , (2000) PARADOXICAL EFFECTS OF PHENOBARBITAL ON MOUSE HEPATOCARCINOGENESIS.TOXICOLOGIC PATHOLOGY. VOL. 28. ISSUE 2. P. 215 -225 | 38 | 83% | 39 |
6 | BANNASCH, P , (1986) PRENEOPLASTIC LESIONS AS END-POINTS IN CARCINOGENICITY TESTING .1. HEPATIC PRENEOPLASIA.CARCINOGENESIS. VOL. 7. ISSUE 5. P. 689-695 | 49 | 89% | 149 |
7 | FARBER, E , SARMA, DSR , (1987) HEPATOCARCINOGENESIS - A DYNAMIC CELLULAR PERSPECTIVE.LABORATORY INVESTIGATION. VOL. 56. ISSUE 1. P. 4-22 | 46 | 71% | 364 |
8 | MARONPOT, RR , (2009) BIOLOGICAL BASIS OF DIFFERENTIAL SUSCEPTIBILITY TO HEPATOCARCINOGENESIS AMONG MOUSE STRAINS.JOURNAL OF TOXICOLOGIC PATHOLOGY. VOL. 22. ISSUE 1. P. 11 -33 | 60 | 35% | 15 |
9 | MOORE, MA , KITAGAWA, T , (1986) HEPATOCARCINOGENESIS IN THE RAT - THE EFFECT OF PROMOTERS AND CARCINOGENS INVIVO AND INVITRO.INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY. VOL. 101. ISSUE . P. 125 -173 | 101 | 43% | 120 |
10 | DRAGAN, YP , HULLY, J , CROW, R , MASS, M , PITOT, HC , (1994) INCORPORATION OF BROMODEOXYURIDINE IN GLUTATHIONE S-TRANSFERASE-POSITIVE HEPATOCYTES DURING RAT MULTISTAGE HEPATOCARCINOGENESIS.CARCINOGENESIS. VOL. 15. ISSUE 9. P. 1939 -1947 | 44 | 71% | 23 |
Classes with closest relation at Level 1 |